Search results
Results from the WOW.Com Content Network
Ribociclib, sold under the brand name Kisqali, is a medication used for the treatment of certain kinds of breast cancer. [4] Ribociclib is a kinase inhibitor. [ 4 ] It was developed by Novartis and Astex Pharmaceuticals .
It may also cause fewer side effects, Teplinksy said. The expanded approval is for patients with HR-positive, HER2-negative breast cancer, the most common form of the disease .
Another remaining question surrounding CDK inhibitors as a therapy is if certain cancers will evade or be resistant to treatment. One study showed that 20% of the patients being treated for metastatic ER+ HER2-breast cancer did not respond at all to treatment with a CDK4/6 inhibitor due to preexisting mutations allowing the cancer cells to continue proliferating despite treatment with the drug ...
The side effects of cyproterone acetate (CPA), a steroidal antiandrogen and progestin, including its frequent and rare side effects, have been studied and characterized.It is generally well-tolerated and has a mild side-effect profile, regardless of dosage, when it used as a progestin or antiandrogen in combination with an estrogen such as ethinylestradiol or estradiol valerate in women.
Conditions such as sleep apnea, hypothyroidism, and depression can hinder weight loss and cause weight gain, according to WebMD. "Many medical conditions are associated with weight gain, so it's ...
Both doctors say that the root cause of menopause symptoms, including weight gain, is caused by a sudden drop in production of estrogen and progesterone, so these are two hormones it can be ...
It's very common for weight gain to start during perimenopause, a few years before menopause, per Mayo Clinic. For many women, this can start in their 40s, and weight gain often continues at about ...
Bisphenol A found in food and beverage packaging is an obesogen showing up in the bodies of about 95% of the human population. [1]Obesogens are certain chemical compounds that are hypothesised to disrupt normal development and balance of lipid metabolism, which in some cases, can lead to obesity.